SKI Market

A+| A| A-|

Indian Indices

Sensex

77,303.63 639.42
( 0.83%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

60,447.00 730.82
(1.22%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Biocon Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532523

INE376G01013

167.0814588

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BIOCON

291.38

56675.04

EPS(TTM)

Face Value()

Div & Yield %

1.2

0.11

Back

birlasoft ltd

Rossari Biotech consolidated net profit rises 4.39% in the September 2025 quarter

Oct 16,2025

Net profit of Rossari Biotech rose 4.39% to Rs 36.88 crore in the quarter ended September 2025 as against Rs 35.33 crore during the previous quarter ended September 2024. Sales rose 17.61% to Rs 586.11 crore in the quarter ended September 2025 as against Rs 498.35 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	586.11	498.35	18
OPM %	12.27	13.23	-
PBDT	67.91	63.27	7
PBT	49.67	48.11	3
NP	36.88	35.33	4

77,303.63 639.42 ( 0.83%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

60,447.00 730.82 (1.22%)

10,387.94 -69.07 (-0.66%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)